Valeant Pharmaceuticals (VRX) Stock: Gaining On Licensing Changes

By |July 1st, 2016|

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)

Valeant Pharmaceuticals is having an incredible day in the market today and for good reason. The company made an announcement early this morning with regard to an agreement it has with AstraZeneca (NYSE: AZN). Today, we’ll talk about the announcement, how the market reacted to the news, and what […]